The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global single cell multiomics market was valued at US$ 2.85 Billion in 2021.
We expect the global single cell multiomics market to exhibit a CAGR of 17.30% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of single-cell multiomics analysis for early diagnosis of the coronavirus infection among population.
The increasing demand of single cell multiomics for personalized medicine and solutions for screening and diagnosing genetic disorders and cell heterogeneity in the micro-environment, is primarily driving the global single cell multiomics market.
Based on the type, the global single cell multiomics market can be segmented into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. Currently, single cell genomics hold the majority of the total market share.
Based on the product type, the global single cell multiomics market has been divided into consumables, instruments, and software. Among these, consumables currently exhibit a clear dominance in the market.
Based on the technique, the global single cell multiomics market can be categorized into single-cell isolation and dispensing and single-cell analysis. Currently, single-cell isolation and dispensing holds the largest market share.
Based on the application, the global single cell multiomics market has been segregated into oncology, cell biology, neurology, and others, where oncology currently exhibits a clear dominance in the market.
Based on the end user, the global single cell multiomics market can be bifurcated into academic institutes, contract research organizations, and pharmaceutical and biotech companies. Currently, academic institutes account for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global single cell multiomics market include 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings), and Thermo Fisher Scientific Inc.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at